CDK4 and breast neoplasm: In breast tumors, the alterations of the CDK4/pRb axis include amplification of CCND1 or CDK4, loss of CDKN2A/B or, less often, loss or mutation of pRb (Ertel et al, 2010; Curtis et al, 2012; The Cancer Genome Atlas Network, 2012).